Made Scientific Unveils Strategic Alliance with Orca Bio for TREGZI™ Manufacturing

Made Scientific's New Partnership with Orca Bio



In a significant advancement for cell therapy, Made Scientific, based in Princeton, New Jersey, has formed a long-term manufacturing partnership with Orca Bio. This collaboration is set to enhance the production and distribution of TREGZI™, an FDA-approved cell therapy targeting blood cancers and autoimmune diseases. The partnership aims to bolster Orca Bio's capabilities by establishing an East Coast production facility, thereby improving access for patients requiring this innovative treatment.

Expanding Operational Footprint



Made Scientific is committed to expanding its operations to meet increasing demands. The company plans to add a new 45,000 square foot facility adjacent to its current headquarters in Princeton. This extension will feature advanced manufacturing suites and quality control laboratories, all designed to support the commercial supply of TREGZI™. As explained by Syed T. Husain, Chairman and CEO of Made Scientific, this expansion demonstrates their dedication to patients' needs by ensuring that production capabilities are not only sufficient but also timely.

The East Coast facility will serve as a vital link, complementing Orca Bio's main manufacturing site located in Sacramento, California. This strategic move allows for a bicoastal production network, which facilitates quicker delivery times for patients on the East Coast, ultimately aiding in improved health outcomes.

Ensuring Reliable Supply



The production of TREGZI™ is unique, as it is tailored specifically for each patient using matched donor cells. Dr. Jeroen Bekaert, co-founder and President of Orca Bio, emphasized the importance of having a reliable supply chain firmly located in Princeton. The new facility not only strengthens their operational capacity but also provides greater access to both domestic and international donor sources, which is crucial for producing tailor-made therapies that meet diverse patient needs.

Long-Term Commitment to Patient Care



Both companies share a vision of long-term commitment to patient care. Made Scientific’s partnership is not just a business arrangement; it reflects a dedication to improving patient lives through advanced medical treatments. By scaling up its operations and investing in quality infrastructure, the company is positioning itself to meet the future demands of cell therapy manufacturing. Their focus on quality and scalability over short-term gains reinforces their commitment to becoming a leader in the field.

About the Companies



Made Scientific


Made Scientific is a premier contract development and manufacturing organization (CDMO) specializing in cell therapies. With GMP facilities in New Jersey and Pennsylvania and plans for further expansion, the company provides agile support to both clinical and commercial stages of cell therapy development.

Orca Bio


Founded with the mission to transform blood cancers and autoimmune disease treatment, Orca Bio employs cutting-edge technology to create bespoke cell therapies. Their innovative approach, using single-cell precision, is positioned to redefine the standards of care within the sector.

By aligning their manufacturing strategies, Made Scientific and Orca Bio are aiming to set new benchmarks in the biopharmaceutical industry, ultimately ensuring that high-precision therapies like TREGZI™ are accessible to those in need. This partnership represents a significant step forward in building a comprehensive network that prioritizes patient care and outcomes.

For additional updates and information regarding this partnership and its outcomes, please visit Made Scientific and Orca Bio.

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.